ProQR Therapeutics N.V. (PRQR)

ProQR Therapeutics Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	118.93	94.78	187.52	75.84	111.95
Cash & Cash Equivalents	118.93	94.78	187.52	75.84	111.95
Cash Growth	25.48%	-49.46%	147.27%	-32.26%	6.03%
Receivables	1.54	59.08	3.4	3.76	1.87
Other Current Assets	0.52	0.61	0.56	0.42	0.85
Total Current Assets	120.99	154.46	191.48	80.02	114.67
Property, Plant & Equipment	16.9	16.24	17.47	18.6	2.44
Long-Term Investments	0	0.62	0.63	0.11	0.43
Total Long-Term Assets	16.9	16.86	18.1	18.71	2.87
Total Assets	137.88	171.32	209.58	98.73	117.54
Accounts Payable	1.54	0.39	0.19	0.22	0.45
Deferred Revenue	64.74	71.21	19.8	0.7	0.71
Current Debt	1.61	3.89	6.31	2.4	0.85
Other Current Liabilities	-33.69	-54.5	1.3	6.99	8.99
Total Current Liabilities	34.2	20.99	27.6	10.3	10.99
Long-Term Debt	18.12	18.08	54.07	31.88	12.71
Other Long-Term Liabilities	44.17	65.57	14.69	0	0
Total Long-Term Liabilities	62.29	83.65	68.75	31.88	12.71
Total Liabilities	96.49	104.64	96.35	42.18	23.7
Total Debt	19.73	21.97	60.37	34.28	13.56
Debt Growth	-10.18%	-63.61%	76.13%	152.78%	44.47%
Retained Earnings	-400.85	-379.11	-317.77	-257.75	-211.75
Shareholders' Equity	41.39	67.07	113.83	57.09	94.33
Net Cash / Debt	99.19	72.8	127.15	41.56	98.39
Net Cash / Debt Growth	36.24%	-42.74%	205.94%	-57.76%	2.28%
Net Cash Per Share	1.22	1.02	1.98	0.83	2.40
Working Capital	86.78	133.47	163.89	69.72	103.67
Book Value Per Share	0.51	0.94	1.77	1.14	2.30

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).